Signalling to drug resistance in CLL

Best Practice & Research. Clinical Haematology
Erin Hertlein, John C Byrd

Abstract

The nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappaB) signalling pathway is constitutively active in a variety of cancers, including chronic lymphocytic leukaemia (CLL). The importance of this signalling pathway identifies it as a prime therapeutic target; however, the complexity and potential side effects of inhibiting NF-kappaB have thus far made the clinical use of NF-kappaB inhibitors a relatively unexplored resource in this disease. This article discusses the role of NF-kappaB in CLL as a common crossroad for pathways promoting drug resistance in CLL. We provide the background on how this pathway contributes to both spontaneous and drug-induced apoptosis. Potential new avenues to regulate this pathway in CLL are also discussed.

References

Jun 1, 1995·Leukemia & Lymphoma·S A JabbarR G Wickremasinghe
Dec 10, 1999·The Journal of Experimental Medicine·F MackayJ L Browning
Feb 28, 2002·Molecular Cell·Guoqing ChenDavid V Goeddel
May 16, 2002·Proceedings of the National Academy of Sciences of the United States of America·Roberta BichiCarlo M Croce
Nov 15, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert Z OrlowskiSteven L Soignet
Jul 12, 2003·Leukemia & Lymphoma·Neil E Kay, Brian T Pittner
Feb 21, 2004·Biochemical and Biophysical Research Communications·Laura SanzAugusto Silva
Feb 18, 2006·Cell Death and Differentiation·H J KimA S Baldwin
Jul 11, 2006·The Journal of Biological Chemistry·Morgan SammonsBrian P Ashburner
Jan 4, 2007·The Journal of Clinical Investigation·Victoria Del Gaizo MooreAnthony Letai
Apr 4, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Syed-Rehan A HussainJohn C Byrd
Apr 5, 2007·Blood·Baochun ZhangHan-Fei Ding
Aug 19, 2007·Cancer Cell·Jonathan J KeatsP Leif Bergsagel
Sep 1, 2007·British Journal of Haematology·Shaun WillimottSimon D Wagner
Nov 24, 2007·Autoimmunity Reviews·Dimitar G EfremovPablo G Longo

❮ Previous
Next ❯

Citations

Jan 15, 2014·Cellular and Molecular Life Sciences : CMLS·Chiara GaspariniGiorgio Zauli
Nov 22, 2011·Expert Opinion on Therapeutic Patents·Jae-Hwan KwakHeesoon Lee
Jul 23, 2014·Seminars in Hematology·Michele Dal BoValter Gattei
Jan 23, 2016·American Journal of Hematology·Damien Roos-WeilOlivier A Bernard
Jul 14, 2011·British Journal of Cancer·C SpagnuoloG L Russo
Mar 17, 2019·Clinical and Experimental Medicine·Giulia DanieleClelia Tiziana Storlazzi
Dec 21, 2016·Macromolecular Bioscience·Ida Franiak-PietrygaMaciej Borowiec
Mar 22, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sneha V GuptaDavid M Lucas
Mar 28, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Emilio CosimoAlison M Michie

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Calcium & Bioenergetics

Bioenergetic processes, including cellular respiration and photosynthesis, concern the transformation of energy by cells. Here is the latest research on the role of calcium in bioenergetics.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.